Ranibizumab 0.3mg/0.05mL (6mg/mL) Injection$146.00
1–9 boxes
$146.00 each
10–24 boxes
8% off
25+ boxes
10% off
Ranibizumab 0.3mg/0.05mL (6mg/mL) Injection
SKU GME1344Eye Care
Product Introduction
Ranibizumab 0.3mg/0.05mL (6mg/mL) is an intravitreal anti-VEGF antibody fragment used in selected diabetic retinal disease. It targets abnormal vessel leakage that can damage central vision.
How to use
An ophthalmologist injects 0.3mg (0.05mL of the 6mg/mL solution) into the vitreous cavity for diabetic macular oedema or diabetic retinopathy, generally at monthly intervals. The vial is single use for one eye; retinal response and eye pressure are monitored.
How it works
Ranibizumab binds VEGF-A and prevents activation of its receptors, reducing abnormal vessel formation and fluid leakage in the retina.
Side effects
Eye discomfort, floaters, conjunctival bleeding and raised eye pressure can occur. Endophthalmitis, retinal detachment and significant intraocular inflammation are serious uncommon risks.
Important information
Active ocular infection or severe intraocular inflammation can preclude injection.
Uses
- Diabetic macular oedema and diabetic retinopathy in an appropriate 0.3mg intravitreal treatment setting.
Benefits
Suppressing VEGF-related leakage helps preserve retinal function and can improve vision in a responsive eye.
Are 0.3mg and 0.5mg automatically interchangeable?
No. Dose selection depends on the retinal condition and the verified preparation; a different number is not simply a stronger version of the same regimen.
Can I drive myself home after a ranibizumab injection?
Arrange for someone else to drive you home. The injection procedure and pupil-dilating drops can temporarily affect vision, so wait until your sight has returned to normal before driving.
Why can treatment continue after vision improves?
Retinal disease can reactivate, so treatment interval follows examination and imaging rather than symptoms alone.
What symptoms after injection need urgent care?
Increasing pain, light sensitivity, marked redness or a new loss of vision needs same-day eye assessment.
How much solution is in the vial compared with one injection?
The single-use vial contains 1.38mg in 0.23mL. The ophthalmologist measures 0.05mL of the 6mg/mL solution to deliver the 0.3mg dose.
Anti-VEGF: a treatment blocking vascular endothelial growth factor. Choroidal neovascularisation: abnormal vessels beneath the retina. OCT: optical coherence tomography imaging.; AR: Ranibizumab 0.3mg حقن; FR: Ranibizumab 0.3mg injection; PT: Ranibizumab 0.3mg injeção; ES: Ranibizumab 0.3mg inyección; RU: Ranibizumab 0.3mg инъекция; ID: Ranibizumab 0.3mg suntikan; VI: Ranibizumab 0.3mg thuốc tiêm; MS: Ranibizumab 0.3mg suntikan; TL: Ranibizumab 0.3mg iniksyon; ZH-SG: Ranibizumab 0.3mg 注射剂